semaglutide and anorexia GLP-1 access a problem for people with eating disorders Eating disorders rise amid popular

Report symptoms like severe dizziness, slow pulse, shortness of breath, or fainting

Uptake in skeletal and cardiac muscle is a saturable active transport process against a concentration gradient [16]

PMID: 12408087 Rights and permissions Copyright information 2025 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG About this chapter Cite this chapter DePace, N.L., Soloway, S., Yayac, M., Colombo, J

Major insurers across the country have cut coverage: Blue Cross Blue Shield affiliates in Michigan, Massachusetts, and other states ended coverage for Wegovy, Zepbound, and Saxenda for weight loss effective January 2025 and January 2026